Free Trial

Trupanion, Inc. (NASDAQ:TRUP) Shares Sold by Two Sigma Advisers LP

Trupanion logo with Finance background

Two Sigma Advisers LP trimmed its position in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 47.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 41,400 shares of the financial services provider's stock after selling 36,800 shares during the period. Two Sigma Advisers LP owned approximately 0.10% of Trupanion worth $1,995,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Jones Financial Companies Lllp increased its holdings in shares of Trupanion by 71.7% during the fourth quarter. Jones Financial Companies Lllp now owns 570 shares of the financial services provider's stock valued at $27,000 after acquiring an additional 238 shares in the last quarter. Coppell Advisory Solutions LLC grew its position in Trupanion by 58.3% during the 4th quarter. Coppell Advisory Solutions LLC now owns 1,249 shares of the financial services provider's stock worth $61,000 after purchasing an additional 460 shares during the last quarter. SBI Securities Co. Ltd. acquired a new position in Trupanion during the 4th quarter valued at approximately $25,000. Swiss National Bank increased its stake in Trupanion by 1.1% during the 4th quarter. Swiss National Bank now owns 66,310 shares of the financial services provider's stock valued at $3,196,000 after purchasing an additional 700 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Trupanion by 4.0% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 18,745 shares of the financial services provider's stock worth $904,000 after buying an additional 717 shares during the last quarter.

Insider Transactions at Trupanion

In related news, CEO Margaret Tooth sold 2,294 shares of the business's stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $31.39, for a total value of $72,008.66. Following the completion of the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at $3,728,629.76. The trade was a 1.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO John R. Gallagher sold 4,000 shares of the firm's stock in a transaction on Thursday, May 29th. The shares were sold at an average price of $47.90, for a total transaction of $191,600.00. Following the sale, the chief operating officer now owns 26,966 shares in the company, valued at approximately $1,291,671.40. This represents a 12.92% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 43,781 shares of company stock worth $1,610,974 over the last quarter. 5.42% of the stock is currently owned by insiders.

Trupanion Stock Performance

Shares of NASDAQ:TRUP traded down $0.46 during midday trading on Monday, reaching $46.73. The company's stock had a trading volume of 772,775 shares, compared to its average volume of 609,717. The company has a quick ratio of 1.66, a current ratio of 1.71 and a debt-to-equity ratio of 0.39. The stock has a fifty day moving average of $40.08 and a 200 day moving average of $43.76. Trupanion, Inc. has a twelve month low of $25.90 and a twelve month high of $57.90. The firm has a market capitalization of $2.00 billion, a PE ratio of -203.17, a P/E/G ratio of 6.02 and a beta of 1.72.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.02. The company had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm's revenue was up 11.7% on a year-over-year basis. During the same period in the prior year, the company earned ($0.16) earnings per share. On average, equities analysts expect that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

TRUP has been the topic of a number of research analyst reports. Stifel Nicolaus dropped their price objective on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a report on Thursday, February 20th. Piper Sandler lowered their price target on Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a research report on Thursday, February 20th. Finally, Lake Street Capital dropped their price target on Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Trupanion currently has an average rating of "Moderate Buy" and a consensus target price of $51.80.

Read Our Latest Research Report on TRUP

Trupanion Company Profile

(Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Further Reading

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Top 3 Defense Stocks to Profit From $175 Billion Golden Dome
Top 5 Stocks for June: AI Picks That Aren’t NVIDIA
This Unique Robotaxi Play Could Deliver 10X Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines